Purpose: Amifostine (WR-2721), a physphorylated aminothiol pro-drag which i
s an analogue of cysteamine, is a selective cytoprotective agent for normal
tissues from the toxicities associated with chemotherapy and irradiation.
Despite a growing number of reports strongly supporting amifostine's clinic
al efficacy, few authors have focused on the biochemical basis of amifostin
e's antioxidant activity. Methods: We report on amifostine's free-radical s
cavenging activity against superoxide (O-2(.-)), hydroxyl (OH-) and lipoper
oxyl radicals in an in vitro model, using pure chemical systems. Amifostine
was dephosphorylated to its active metabolite, WR-1065, by adding 10% non-
heat-inactivated serum; different amifostine concentrations (1, 10, 50, 100
mu M and 200 mu M) and pH conditions (pH 5, 7.4 and 9) were tested. Result
s: Independent of the concentration, amifostine exhibited no major activity
against O-2(.-) ions, neither did any pH variations in the experimental mo
del provide any scavenger effects of the drug against O-2(.-) radicals. On
the other hand, the protective effect of amifostine against OH- radicals wa
s confirmed, yielding an EC50 of 255 mu M at pH 7.4 and 230 mu M at pH 5 Fi
nally, amifostine exhibited scavenging activity against spontaneous lipoper
oxidation, but no apparent antioxidant effect on iron ascorbate-induced lip
operoxidation. Conclusions: With this in vitro study, we are able to confir
m the scavenging activity of the chemo- and radioprotector amifostine, whos
e activity seems to be particularly important from a biological point of vi
ew, since it is exerted mainly against highly reactive OH-.